AHA Coding Clinic® for ICD-9 - 2006 Issue 4; VOLUMES 1 AND 2 NEW/REVISED CODES
Cytologic Evidence of Malignancy
Effective October 1, 2006, cytologic evidence of malignancy has been removed as an inclusion term from code 795.04, Papanicolaou smear of cervix with high grade squamous intraepithelial lesion (HGSIL), and a new unique code created. 795 Other and nonspecific abnormal cytological, histological, immunological and DNA test findings 795.0 Abnormal Papanicolaou smear of cervix and cervical HPV 795.04 Papanicolaou smear of cervix with high grade squamous intraepithelial lesion (HGSIL) Delete Cytologic evidence of carcinoma New code 795.06 Papanicolaou smear of cervix with cytologic evidence of malignancy ...
Subscribe or sign in to view the full article.
Article Overview
This short coding update covers a revision to cervical cytology reporting in ICD-9-CM and the addition of a new code tied to malignancy-related cytologic findings. It is relevant to coders, billing staff, clinical documentation teams, and compliance personnel working with laboratory, pathology, and women’s health records. The article provides a brief before-and-after view of the change and identifies the effective date.
Why This Topic Matters
Updates like this affect how abnormal Pap smear findings are captured in claims and records. Accurate awareness of the effective date and revised code set helps reduce reporting errors and supports consistent documentation handling.
What You Will Learn
- What changed in the ICD-9-CM abnormal cervical cytology category
- Which update introduced a new code in this area
- When the coding change became effective
- How the article frames the reporting topic at a high level
Who Should Read This
- Medical coders
- Coding auditors
- Billing staff
- Clinical documentation specialists
- Compliance professionals
- Pathology and laboratory coding staff
- Women’s health practices
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com